Matheson LLP's international focus and commitment to the life sciences sector has brought it a wealth of top clients in the pharmaceutical and medtech sectors, leading to a steady pipeline of transactional, corporate advisory and regulatory advisory instructions. It has continued to work on some of the highest value cross-border transactions in the sector The firm is also a healthcare litigation heavyweight, especially medical malpractice and product liability litigation, while also having a strong presence in healthcare transactions, including a number of recent hospital and nursing home deals. Litigator Rebecca Ryan is a leader in healthcare, disease and product liability cases. Kate McKenna is a key figure for life sciences regulatory matters, while David Fitzgibbon is at the forefront of life sciences M&A, along with John Coary. Emma Doherty specialises in corporate governance for both healthcare and life sciences businesses.
L’éditorial du Legal 500
- Profil
- Réseaux sociaux
Clients clés
- Aerogen
- Agilent Technologies
- Arena Pharmaceuticals
- Astrix Technology
- BioIQ
- Bon Secours Mercy Health
- Centrient Pharmaceuticals
- Chemocentryx
- Ethypharm SAS
- Grifols
Points forts
- Advised on all aspects of the proposed acquisition of Horizon Therapeutics by Pillartree.
- Advised Macquarie Asset Management in relation to its agreement to acquire the Beacon Hospital Group.
- Advised Medlab and Sonic Healthcare Ireland, and their insurers, in relation to a number of complex and high value negligence actions arising from Cervical Check screening.
Avocats
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Responsable de la pratique
Rebecca Ryan; Emma Doherty; Kate McKenna
Autres avocats clés
David Fitzgibbon; John Coary